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Abstract
To date there are 26 human matrix metalloproteinases (MMPs) which are classified according to
their substrate specificity and structural similarities. The four major subgroups of MMPs are
gelatinases, interstitial collagenases, stromelysins, and membrane-type matrix metalloproteinases
(MT-MMPs). This study investigates the expression of 26 MMPs, which have been shown to play a
role in cancer metastasis. Breast tissues and cell lines derived from African American patients and
Caucasian patients were assayed to demonstrate alterations in the transcription of genes primarily
responsible for degrading the extracellular matrix (ECM). The expression levels of the extracellular
matrix and adhesion molecules were analyzed using the gene array technology. Steady state levels
of mRNAs were validated by RT-PCR analysis. Total RNA was isolated from tissue and cell lines
and used in the RT-PCR assays. From this data, differential expression of MMPs between 6 breast
cancer cell lines and 2 non-cancer breast cell lines was demonstrated. We have performed an in
vitro comparison of MMP expression and established differences in 12 MMPs (3, 7, 8, 9, 11–15, 23B,
26, and 28) expression between African American and Caucasian breast cell lines. Thus, evidence
indicates that altered expression of MMPs may play a role in the aggressive phenotype seen in
African American women.
Introduction
In 2003, it was estimated that approximately 1.3 million
Americans would be diagnosed with invasive cancer. Of
this group, racial/ethnic minorities account for a dispro-
portionate number of these cancers [1,2]. Invasive breast
cancer usually begins in either the lobules or the ducts of
the breast. These tumors then metastasize via the breast
associated and thoracic lymphatic tissue [3]. The inci-
dence of breast cancer in Caucasian women (112 out of
100,000) is higher than in African American women (AA)
(95 out of 100,000) after the age of 40, however, the mor-
tality suffered by (AA)(37 out of 100,000) is higher than
Caucasian women (CAU) (31 out of 100,000) at every age
[4]. Thus a greater percentage of AA women die from
breast cancer and resulting metastasis. In 2004, an esti-
mated 215,990 new cases of invasive breast cancer is
expected to occur among women in the United States [5].
Breast cancer is the most common cancer among AA
women; however, the rate of newly diagnosed cases is
about 13% lower than CAU women [6]. There is
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accumulating evidence that AA women have a higher fre-
quency of more aggressive tumor types, which have been
shown to lead to higher mortality rates. Studies show that
compared Caucasian women (CAU), African American
women (AA), regardless of age had proportionally more
Grade III tumors and fewer Grade I and II tumors for all
stages combined and for each individual stage group [7].
The grade of cancer has been shown to be a prognostic fac-
tor with higher-grade tumors being associated with
reduced survival [7]. The most common cause of death in
breast cancer patients is metastasis of breast cancer cells to
bones, lungs, liver and brain and the progressive growth
of the cancer at these sites [7,8]. Therefore, controlling
breast cancer metastasis represents an effective method of
preventing or slowing disease progression.
The extracellular matrix (ECM) is a complex structural
entity surrounding and supporting organs and tissues of
the body. The ECM plays a key role in cell-cell signaling,
wound repair, cell adhesion and tissue function. Recent
studies suggest that cell adhesion proteins located on
breast cancer cells interact with the ECM [7]. This interac-
tion induces increased production by the breast cancer
cells of proteins that degrade the ECM. This degradation
enables the tumor cells to invade the surrounding tissue
and ultimately enter the circulatory system. Once they are
in circulation, tumor cells travel to other organ sites where
they progressively grow [7].
The matrix metalloproteinases (MMPs) are a family of
structurally and functionally related endoproteinases that
are involved in the degradation of the ECM. Currently,
there are 26 identified human matrix metalloproteinases,
which are classified according to their substrate specificity
and structural similarities [8]. Abnormal expression of
these proteins contributes to various pathological proc-
esses including rheumatoid arthritis and tumor growth,
invasion and metastasis. The four main subgroups of
MMPs are the interstitial collagenases, which catalyze deg-
radation of fibrillar forms of collagen, the gelatinases
which degrade gelatin and collagen that are abundant in
basement membranes, the stromelysins, which degrade
various substrates including proteoglycans, laminin and
collagen I, II, and III and the membrane-type MMPs
which have been shown to catalyze activation of progela-
tinase A, to degrade a variety of ECM substrates and to
function as a fibrinolytic enzyme in the absence of plas-
min [9].
MMP expression has bee shown to be elevated during
development, pregnancy, and involution and has been
shown to be related to tumor cell invasiveness [10]. This
study investigates the expression levels of the 26 identified
MMPs, which have been shown to play a role in the met-
astatic process using breast tissues and cell lines derived
from AA and CAU women.
Materials and Methods
Cell Culture and Tissue RNA
All cell lines were purchased from American Type Culture
Collection (Rockville, MD, USA). Cells were propagated
in the recommended media and given new media every 2
to 3 days until 90% confluent (see table 1). Human Breast
Tissue RNA was purchased from Ambion (Austin, TX).
RNA Extractions
RNA was extracted from the cell line using the RNAqueous
(Ambion, Austin, TX). Cells were collected by low speed
centrifugation and lysed by adding 200 µl of Lysis/Bind-
ing Solution. An equal volume of 64% ethanol was added
to the lysate. The lysate/ethanol mixture was transferred to
the RNAqueous Filter Cartridge and centrifuged for 1
minute at 13,400 rpm. The flow through was discarded
and 700 µl of Wash Solution 1 was added to the RNAque-
ous Filter Cartridge and centrifuged for 1 minute. The col-
umn was washed twice with 500 µl of Wash Solution 2/3
and eluted with 110 µl Elution Solution. Isolated RNA
was quantitated using the UltraSpec 2000 (Pharmacia
Biotech). All RNA samples were stored at -70°C in RNA
elution solution until further use.
Gene array
The Extracellular Matrix and Adhesion Molecule gene
arrays were obtained from SuperArray (Frederick, MD).
The array membranes were pre-hybridized with GEA
hybridization solution and denatured salmon sperm
DNA at 60°C for two hours. For each RNA sample, a labe-
ling mix consisting of 4 µl 5X GEA labeling buffer, 2 µl
biotin-16-dUTP, 1 µl RNase inhibitor, 1 µl reverse tran-
scriptase, and 2 µl RNase-free water was prepared and an
aliquot of 3 µg of RNA was added to each respective thin-
walled PCR tube. The cDNA labels were created using a
cycle of 3 minutes at 70°C, 2 minutes at 42°C, and an
additional 90 minutes at 42°C. Two microliters of stop
buffer was added and the mix denatured at 94°C for 5
minutes. The labeled cDNA was added to the membrane
and allowed to hybridize overnight. The membranes were
washed with 2X SSC/0.1% SDS and 0.1X SSC/0.5% SDS,
blocked with blocking solution, and the probes were
detected using AP-Strepavidin, specific buffers, CDP-Star
and subsequent exposure to X-ray film for 30 seconds to 5
minutes. The autoradiograms were analyzed using ScanA-
lyzer and GEArray Analyzer (SuperArray, Frederick, MD).
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR)
The RT-PCR reactions were performed in a P/E GeneAmp
9700 thermocycler (Perkin-Elmer Co., Norwalk CT),
using the Access RT-PCR system (Promega, Madison, WI).Journal of Carcinogenesis 2004, 3:15 http://www.carcinogenesis.com/content/3/1/15
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RT-PCR expression of MMPs in African American and Caucasian breast cell lines and tissue Figure 1
RT-PCR expression of MMPs in African American and Caucasian breast cell lines and tissue.
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The reaction mixes were prepared by combining 27. 5 µl
of nuclease free water, 10 µl of AMV, 1 µl Tfl 5X reaction
buffer, 2 µl dNTP mix, 50 pM of upstream primer, 50 pM
of downstream primer in 1.5 µl volume each, 3 µl 25 mM
MgSO4, 1.0 µl AMV reverse transcriptase, Tfl DNA
polymerase and 1 µg of total RNA in a 0.5 ml thin walled
Eppendorf tube on ice. The reaction mixes were then vor-
texed for 5 seconds and centrifuged. The PCR cycling pro-
file was as follows: 48°C for 1 minute for reverse
transcription of the RNA into cDNA, 94°C for 4 minutes
to deactivate the reverse transcriptase, and 30 cycling
sequences of denaturing at 94°C for 45 seconds, anneal-
ing at 55°C for 30 seconds, and extension at 72°C for 1
minute with a final extension at 72°C for 10 minutes. An
aliquot of 20 µl of each RT-PCR reaction were run on
1.2% agarose gels, stained with ethidium bromide, photo-
graphed and subjected to densitometic measurements
using the Chemi-Imager Tm 4000 (Alpha Innotech, Cor-
poration, San Leandro, CA).
Results
Gene Array Analysis
Gene arrays were utilized to explore and compare the
expression levels of extracellular matrix adhesion mole-
cules in AA and CAU breast cancer cells. The array revealed
elevated expression in 36% of the genes in AA samples
when compared to their CAU counterparts. Of those ele-
vated genes, 31% were from the cell membrane adhesion
molecules group, 17% from the extracellular matrix pro-
teins functional gene group, 37% from the proteases cate-
gory, and 14% were protease inhibitors. Initial results of
the gene array indicated a significant elevation of the pro-
teases (data not shown). To further evaluate this, we pro-
ceeded with direct analysis of all known MMPs.
MMP RT-PCR Analysis
Comparison of the individual relative densities between
AA and CAU women revealed elevated expression in 12 of
the 26 MMPs (3, 7, 8, 9, 11, 12, 13, 14, 15, 23B, 26, and
Table 2: Matrix Metalloproteinase Expression Assessment by RT-PCR
African American Normal Caucasian
Cell Lines 2315 2320 2329 A1N4 10A MCF7 Hs578t 2336
MMPs
1 6 ± 2.7 12 ± .58 11 ± 1.15 5 5.7 6 ± 2.7 15 ± 2 11 ± 2.1
2 45.3 ± 4.2 32 ± .58 13.3 ± .58 6.7 11 11.7 ± 7.8 59 ± 1 33 ± 11
3 53 ± 11.5 47.3 ± 11 64 ± 7 9 14.3 26.5 18.3 40
7 73.3 ± 2.3 40.67 ± 2.1 17.6 ± 2.5 5.3 45.3 9 ± 1.7 38 ± 14.53 36.7 ± 4
8 14 ± 2.5 17 ± 2.5 16 ± 2.1 5 6 10 ± 1 15 ± 1.2 12 ± 1
9 66 ± 3 43 ± 5.2 18 ± 5.5 42.3 74.3 7.3 ± 1.5 28 ± 2.7 20.3 ± 5.13
10 7.3 ± .58 26 ± 1.7 18.7 ± 5.5 5.3 5 9.3 ± 1.15 66.3 ± 4 11.3 ± 1.5
11 11 ± 2 15.7 ± 2.9 15 ± 5 5 4 10 ± 4 13 ± 3.79 14 ± 0.58
12 10 ± 4 18 ± 8.9 16 ± 3.6 4 7 5 ± 1.15 5 ± 1 7 ± 2.1
13 10 ± 2 21.7 ± 4.2 7.7 ± 1.2 4 73.67 8.3 ± 2.1 18.7 ± 3.5 6.7 ± 1.15
14 12 ± 3 13.7 ± 1.5 16 ± 5 7 10 13 ± 8.5 11 ± 1.5 14 ± 3.1
15 70 ± 2.7 30 ± 0.58 57.7 ± 6.3 18 7.67 46.3 ± 4.5 81.3 ± 7.5 26.3 ± 6.8
16 8.7 ± 4 7.7 ± 1 15.7 ± 4 7.67 7.67 16 ± 2.9 16 ± 1 8 ± 2.7
17 N/D N/D N/D N/D N/D N/D N/D N/D
19v1 4 ± 1 7.3 ± .58 5 ± 1 5.33 4.33 5.3 ± 1.5 4.7 ± .58 11 ± 3.5
19v3 16 ± 6 13.3 ± 2.9 21.3 ± 8.7 15.3 10 18.3 ± 6.1 24 ± 4.2 25 ± 5
19v6 9.7 ± 4.6 9 ± .58 8 ± 5.2 7 6 12 ± 2.1 11 ± 2.1 9 ± 2.7
19v9 10 ± 1.0 10 ± 3.5 11 ± 2.0 7 7 10 ± 5 10 ± 2.0 10 ± 2.3
20 10.3 ± 3.2 45 ± .58 12.3 ± 2.1 11 9.3 23.7 ± 12.4 37.7 ± 6.0 11 ± 1
23A 5.7 ± 1.5 12 ± 2.0 8.7 ± 1.5 7 7 10 ± 2.8 5.7 ± .58 6.3 ± .58
23B 7 ± 1.1 32 ± 10.6 19.3 ± 1.5 3 7.3 10 ± 1.4 9.7 ± 1.5 12.7 ± 3.2
24 33 ± 1.2 19.7 ± 1.2 36 ± 1 18.67 30.2 33.7 ± 1 35 ± .58 37 ± 1.5
25 8 ± 1 12 ± 5.2 9 ± 1.0 5 6 13 ± 1.5 12.7 ± 1.0 7 ± 2.0
26 11 ± 1.0 11 ± 1.7 9 ± 2.5 11 8 10 ± 2 7 ± .58 9 ± 1.0
27 19 ± 7.2 19 ± 6.0 18 ± 8.0 6.7 11.67 15 ± 2.0 20 ± 13.2 19 ± 1.0
28 9 ± 5.6 14 ± 5.7 7 ± 2.0 15 18 7 ± .58 10 ± .58 9 ± 6.0
RT-PCR expression of MMPs in AA and CAU cells. Elevated expression in AA vs. CAU denoted in bold. Mean ± SD N/D: not 
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28) (Figure 1 and Table 2). Elevated expression of MMP-
3, 7, 8, 9, 11, 12, 13, 14, 23B, 26 and 28 in AA breast can-
cer cells was observed when the overall averages of the
expression levels of all AA and CAU women cell lines were
compared (Table 3).
Discussion
Little is known as to why the incidence of breast cancer is
lower yet mortality is higher in African American women.
Many studies speculate that this is only a socio-economi-
cal problem [11]. However this investigation provides
another possibility that may reveal molecular mecha-
nisms that contribute to the increased mortality of AA
women with breast cancer. The major threat to patients
with breast cancer is tumor invasion and metastasis [12].
Tumor invasion is a complex process that requires interac-
tion between the invasive cells and the ECM [13]. This
process involves a cascade of events including angiogen-
esis, local invasion, and intravasation. One of these criti-
cal steps involves the proteolytic degradation of the ECM
and basement membrane. This is partially done by the
matrix metalloproteinases. One aspect related to cancer
progression has been considered in numerous studies is
the association of MMP expression with tumor grade and
aggressiveness [14].
The GEArray Q Series Human Extracellular Matrix and
Adhesion Molecules Gene Array were used to determine
the expression profiles of various types of matrix and
adhesion molecules. The array was divided into four com-
ponents: cell adhesion molecules, extracellular matrix
proteins, proteases and protease inhibitors. From analysis
of the gene array, altered expression was observed in many
of the proteases. These findings led to further study of the
matrix metalloproteinases (data not shown).
Gene Array analysis of AA and CAU breast cancer cells
indicates that there is altered expression of the genes in
the Extracellular matrix and adhesion molecules, particu-
larly the proteases. This group included 17 MMPs of
which ten displayed elevated expression in AA women.
RT-PCR was performed to confirm the results of the gene
array. We observed elevated expression of 12 MMPs in AA
cell lines when compared to their CAU counterparts.
These include one gelatinase (MMP-9), two interstitial
collagenases (MMP-8, and 13), 3 stromelysins (MMP-3, 7,
11), two MT-MMPs (MMP-14 and -15) and 4 uncatego-
rized MMPs (MMP-12, 23B, 26, and 28). There was no
MMP-17 expression detected in any of the cell lines (Fig-
ure 1).
Studies have shown that normal mammary gland expres-
sion of MMPs is low except during times of development,
pregnancy, and involution [10,15,16]. However, during
pathologic states such as breast cancer, increased levels of
MMPs have been reported in breast tumor cells as well as
in the surrounding non-cancerous breast tissue [17].
Our results suggest that there is altered expression of
MMPs in cell lines derived from AA and CAU women. It
also demonstrates that there is greater expression of
MMPs in AA women than in CAU women. This investiga-
tion indicates that altered expression of MMPs may play a
role in the aggressive phenotype seen in AA women. This
evidence suggests that the elevated expression levels of 12
MMPs may be a contributing factor in the higher mortality
rates of AA breast cancer patients. This study is significant
because it may reveal biomarkers of metastasis in AA
women. To date, this is the first study to extremely
investigate MMP expression in cell lines derived from Afri-
can American patients.
Table 3: Averaged Relative Density of MMP Expression For 
AAW CAU and Normal Cell Lines
AAW CAU Normal
MMPs
1 3.2 3.4 5.35
2 9.6 11.5 11.3
3 18.3 8.4 11.6
7 14.63 9.3 25.3
8 5.37 4.18 5.5
9 14.1 6.2 58.3
10 5.8 9.7 5.1
11 4.62 4.2 4.5
12 4.9 2 5.5
13 4.4 3.7 38.8
14 4.63 4.3 8.5
15 17.5 17.1 12.8
16 3.6 4.5 7.67
17 N/D N/D N/D
19v1 1.8 2.3 4.83
19v3 5.6 7.5 12.65
19v6 3.0 3.6 6.5
19v9 3.4 3.4 7
20 7.5 8.0 10.1
23A 2.9 2.4 7
23B 6.5 3.7 5.1
24 9.9 11.7 24.4
25 3.2 3.7 5.5
26 3.5 2.9 9.5
27 6.1 6 9.1
28 3.3 2.96 16.5
RT-PCR expression of MMPs in AA, CAU cancer cell lines 
and Normal cell lines.. Elevated expression in AA -vs- CAU 
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Table 1: Cell Lines and Tissue Samples
Human Breast Tissue Normal breast tissue (derived from CAU)
MCF-10A Mammary gland, fibrocystic disease (CAU)
A1N4 Mammary epithelial, chemically transformed (CAU)
CAUCASIAN (CAU)
HS578T Mammary gland; breast; carcinoma
MCF-7 Mammary gland; breast; epithelial; metastatic site: pleural effusion adenocarcinoma
CRL-2336 Mammary gland epithelial, primary ductal carcinoma
AFRICAN AMERICAN (AA)
CRL-2315 Breast, primary ductal carcinoma
CRL-2329 Carcinoma, ductal, primary; breast; mammary gland
CRL-2320 Carcinoma, ductal, breast; mammary gland; from metastatic site: lymph node